Yuxi Zhou
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Demographic characteristics and disease severity associated with IgA/IgG deposition patterns in autoimmune bullous diseases: a cohort study based on a registry database.
Journal: Frontiers in immunology
Published: January 22, 2025
Factors associated with persistent anti-desmoglein positivity after remission in pemphigus vulgaris: a prospective registry-based cohort study.
Journal: Frontiers in immunology
Published: January 08, 2025
ESENA: A Novel Spatiotemporal Event Network Information Approach for Mining Scalp EEG Data.
Journal: Brain and behavior
Published: April 10, 2024
Anti-p200 pemphigoid recurred with erythema multiforme-like lesions.
Journal: The Journal of dermatology
Published: February 08, 2024
The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study.
Journal: The Journal of dermatological treatment
Published: January 22, 2024
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab.
Journal: The Journal of dermatology
Published: September 15, 2023
Refractory atypical IgA pemphigus successfully treated with apremilast.
Journal: The Journal of dermatology
Published: August 12, 2023
Evaluation of Dupilumab in Patients With Bullous Pemphigoid.
Journal: JAMA dermatology
Published: August 02, 2023
Anti-laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone.
Journal: The Journal of dermatology
Published: April 26, 2023
Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review.
Journal: Frontiers in immunology
Published: April 06, 2023
Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner.
Journal: EMBO reports
Published: August 10, 2021
Last Updated: 09/26/2026